10x Genomics Inc (NASDAQ:TXG) price closed higher on Friday, May 03, jumping 4.53% above its previous close.
A look at the daily price movement shows that the last close reads $26.29. Taking into account the 52-week price action we note that the stock hit a 52-week high of $63.57 and 52-week low of $24.60. The stock subtracted -23.11% on its value in the past month.
10x Genomics Inc, which has a market valuation of $3.29 billion. Analysts tracking TXG have forecast the quarterly EPS to shrink by -0.48 per share this quarter, while the same analysts predict the annual EPS to hit -$1.61 for the year 2024 and up to -$1.01 for 2025. In this case, analysts estimate an annual EPS growth of 26.10% for the year and 37.30% for the next year.
On average, analysts have forecast the company’s revenue for the quarter will hit $151.01 million, with the likely lows of $149.2 million and highs of $153 million. The average estimate suggests sales growth for the quarter will likely rise by 2.90% when compared to those recorded in the same quarter in the last financial year. Staying with the analyst view, there is a consensus estimate of $669.68 million for the company’s annual revenue in 2024. Per this projection, the revenue is forecast to grow 8.20% above that which the company brought in 2024.
On the technical perspective front, indicators give TXG a short term outlook of 100% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 100% Sell.
The overview shows that TXG’s price is at present -10.54% off the SMA20 and -24.33% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 34.10, with weekly volatility standing at 7.24%. The indicator jumps to 5.37% when calculated based on the past 30 days. 10x Genomics Inc (NASDAQ:TXG)’s beta value is holding at 1.94, while the average true range (ATR) indicator is currently reading 1.85.
An analysis of the 10x Genomics Inc (NASDAQ:TXG) stock in terms of its daily trading volume indicates that the 3-month average is 1.57 million.
Current records show that the company has 105.04M in outstanding shares. The insiders’ percentage holdings are 17.70% of outstanding shares while the percentage share held by institutions stands at 81.36%. But the -50.89% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
